Skip to main content
All lobbying filings

INVARIANT LLC

INVARIANT LLC filed a Q2 report for GLYTEC, LLC on July 16, 2026, reporting $60,000 in lobbying income.

Lobbying for GLYTEC, LLC · Insulin management software

All filings by INVARIANT LLC · Everything GLYTEC, LLC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 16, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Educate policymakers on the importance of effective glycemic management practices.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem